- Home
- SRL vs OPTN Comparison
SRL vs OPTN Comparison
Compare SRL & OPTN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRL
- OPTN
- Stock Information
- Founded
- SRL 2017
- OPTN 2010
- Country
- SRL China
- OPTN United States
- Employees
- SRL N/A
- OPTN N/A
- Industry
- SRL Professional Services
- OPTN Biotechnology: Pharmaceutical Preparations
- Sector
- SRL Consumer Discretionary
- OPTN Health Care
- Exchange
- SRL Nasdaq
- OPTN Nasdaq
- Market Cap
- SRL 115.0M
- OPTN 92.8M
- IPO Year
- SRL N/A
- OPTN 2017
- Fundamental
- Price
- SRL $7.70
- OPTN $9.28
- Analyst Decision
- SRL
- OPTN Hold
- Analyst Count
- SRL 0
- OPTN 3
- Target Price
- SRL N/A
- OPTN $9.00
- AVG Volume (30 Days)
- SRL 4.1K
- OPTN 106.0K
- Earning Date
- SRL 05-06-2025
- OPTN 05-13-2025
- Dividend Yield
- SRL 3.48%
- OPTN N/A
- EPS Growth
- SRL N/A
- OPTN N/A
- EPS
- SRL N/A
- OPTN N/A
- Revenue
- SRL $33,997,735.00
- OPTN $78,226,000.00
- Revenue This Year
- SRL N/A
- OPTN $30.49
- Revenue Next Year
- SRL N/A
- OPTN $13.51
- P/E Ratio
- SRL N/A
- OPTN N/A
- Revenue Growth
- SRL N/A
- OPTN 10.20
- 52 Week Low
- SRL $5.74
- OPTN $4.82
- 52 Week High
- SRL $9.99
- OPTN $20.03
- Technical
- Relative Strength Index (RSI)
- SRL 48.98
- OPTN 78.46
- Support Level
- SRL $7.45
- OPTN $9.14
- Resistance Level
- SRL $7.65
- OPTN $9.30
- Average True Range (ATR)
- SRL 0.32
- OPTN 0.14
- MACD
- SRL -0.01
- OPTN -0.10
- Stochastic Oscillator
- SRL 51.32
- OPTN 96.36
About SRL Scully Royalty Ltd.
Scully Royalty Ltd is a royalty-based company that maximizes earnings upon its iron ore royalty interest. The company's business segments include Royalty, which includes an interest in an iron ore mine; Industrial, which includes projects in resources and services; Merchant Banking, which comprises regulated merchant banking activities; and others. The majority of the revenue is generated from the Royalty segment. The company's geographical segments include Canada, Africa, America, Asia, and Europe, out of which Canada accounts for the majority of the revenue.
About OPTN OptiNose Inc.
OptiNose Inc is a specialty pharmaceutical company focuses on the development and commercialization of products for patients treated by ear, nose, and throat (ENT), and allergy specialists. Its first commercial product, XHANCE (fluticasone propionate) nasal spray, 93 microgram (mcg), is a therapeutic utilizing the proprietary Exhalation Delivery System (EDS) that delivers topically-acting corticosteroid for the treatment of chronic rhinosinusitis with and without nasal polyps.